ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
2.110
-0.240 (-10.21%)
At close: Feb 27, 2026, 4:00 PM EST
2.030
-0.080 (-3.79%)
After-hours: Feb 27, 2026, 7:25 PM EST

ALX Oncology Holdings Market Cap

ALX Oncology Holdings has a market cap or net worth of $276.83 million as of February 27, 2026. Its market cap has increased by 390.52% in one year.

Market Cap
276.83M
Enterprise Value
231.81M
1-Year Change
390.52%
Ranking
Category
Stock Price
$2.11

Market Cap Chart

Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $276.83M, a decrease of -73.79%. That is a compound annual growth rate of -21.21%.

History

DateMarket Cap% Change
Feb 27, 2026276.83M351.84%
Dec 31, 202561.27M-30.44%
Dec 31, 202488.08M-88.13%
Dec 29, 2023741.80M61.50%
Dec 30, 2022459.31M-47.23%
Dec 31, 2021870.34M-74.66%
Dec 31, 2020 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Adlai Nortye 290.04M
Fennec Pharmaceuticals 289.96M
AC Immune 289.90M
Puma Biotechnology 287.23M
Opus Genetics 286.89M
Minerva Neurosciences 285.61M
Inhibikase Therapeutics 280.40M
Abeona Therapeutics 277.46M
Market Cap Rankings